These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant. Takada Y; Sasaki J; Ogata S; Nakanishi T; Ikehara Y; Arakawa K Biochim Biophys Acta; 1990 Apr; 1043(2):169-76. PubMed ID: 2107878 [TBL] [Abstract][Full Text] [Related]
6. Structural and functional properties of natural and chemical variants of apolipoprotein A-I. Jonas A; von Eckardstein A; Churgay L; Mantulin WW; Assmann G Biochim Biophys Acta; 1993 Feb; 1166(2-3):202-10. PubMed ID: 8443238 [TBL] [Abstract][Full Text] [Related]
7. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1. Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533 [TBL] [Abstract][Full Text] [Related]
8. Activation of lecithin cholesterol acyltransferase by human apolipoprotein E in discoidal complexes with lipids. Zorich N; Jonas A; Pownall HJ J Biol Chem; 1985 Jul; 260(15):8831-7. PubMed ID: 3926761 [TBL] [Abstract][Full Text] [Related]
9. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function. Chung BH; Anatharamaiah GM; Brouillette CG; Nishida T; Segrest JP J Biol Chem; 1985 Aug; 260(18):10256-62. PubMed ID: 4019511 [TBL] [Abstract][Full Text] [Related]
10. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia. Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923 [TBL] [Abstract][Full Text] [Related]
11. Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation. Emmanuel F; Steinmetz A; Rosseneu M; Brasseur R; Gosselet N; Attenot F; Cuiné S; Séguret S; Latta M; Fruchart JC J Biol Chem; 1994 Nov; 269(47):29883-90. PubMed ID: 7961983 [TBL] [Abstract][Full Text] [Related]
12. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I. Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091 [TBL] [Abstract][Full Text] [Related]
13. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity. Sparks DL; Frank PG; Neville TA Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105 [TBL] [Abstract][Full Text] [Related]
14. Studies on the cofactor requirement for the acylation and hydrolysis reactions catalyzed by purified lecithin-cholesterol acyltransferase. Effect of low density lipoproteins and apolipoprotein A-i. Subbaiah PV; Chen CH; Albers JJ; Bagdade JD Atherosclerosis; 1982 Nov; 45(2):181-90. PubMed ID: 7159494 [TBL] [Abstract][Full Text] [Related]